2(3H)-benzoxazolone and 2(3H)-benzothiazolone derivatives: Novel, potent and selective σ1 receptor ligands

European Journal of Pharmacology

Volumn 335, Issue 2-3, 1997, Pages 267-273

  Ucar, Huseyin ^a   Cacciaguerra, Silvia ^b   Spampinato, Santi ^b   Van Derpoorten, Kim ^a   Isa, Majed ^a   Kanyonyo, Martial ^a   Poupaert, Jacques H ^a  

^a UNIVERSITÉ CATHOLIQUE DE LOUVAIN   (Belgium)

^b UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

Receptor; 2(3H) Benzothiazolone; 2(3H) Benzoxazolone; 3H (+) Pentazocine; Anticonvulsant

Indexed keywords

1 (3,4 DIMETHOXYPHENETHYL) 4 (3 PHENYLPROPYL)PIPERAZINE; 1 (3,5 DIMETHOXYPHENETHYL) 4 (3 PHENYLPROPYL)PIPERAZINE; 2 [4 METHOXY 3 (2 PHENYLETHOXY)PHENYL] N,N DIPROPYLETHYLAMINE; BENZOTHIAZOLE DERIVATIVE; BENZOXAZOLE DERIVATIVE; HALOPERIDOL; LIGAND; PENTAZOCINE; RECEPTOR SUBTYPE; SIGMA OPIATE RECEPTOR; SIGMA RECEPTOR LIGAND; UNCLASSIFIED DRUG;

ANIMAL MODEL; ANIMAL TISSUE; ANTICONVULSANT ACTIVITY; ARTICLE; BINDING AFFINITY; BINDING SITE; BRAIN MEMBRANE; CONTROLLED STUDY; DRUG SYNTHESIS; GUINEA PIG; IN VITRO STUDY; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; MOUSE; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL; SYNAPTIC TRANSMISSION;

ANIMALS; ANTICONVULSANTS; BENZOXAZOLES; BRAIN; CONVULSANTS; ELECTROSHOCK; GUINEA PIGS; LIGANDS; MALE; MICE; MOTOR ACTIVITY; NEUROPROTECTIVE AGENTS; PENTYLENETETRAZOLE; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, SIGMA; SEIZURES; STRUCTURE-ACTIVITY RELATIONSHIP; THIAZOLES;

EID: 0030868834     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(97)01248-X     Document Type: Article

References (47)

1. 2 receptor affinity and subtype selectivity. Eur. J. Pharmacol. 278:1995;257-260.
2. Bradford M.M. A rapid and sensitive method for the quantification of microgram quantities of protein utilizing the principle of protein dye-binding. Anal. Biochem. 72:1976;248-254.
3. 3H ]-spiroperidol on rat striatal membranes Eur. J. Pharmacol. 50:1978;283-284.
4. Carter A.J. Many agents that antagonize the NMDA receptor-channel complex in vivo also cause disturbances of motor coordination. J. Pharmacol. Exp. Ther. 269:1994;573-580.
5. 1 binding sites in guinea pig brain. Eur. J. Pharmacol. 251:1994;R1-R2.
6. Contreras P.C., Rice K.C., Jacobson A., O'Donohue T.L. Stereotyped behavior correlates better than ataxia with phencyclidine-receptor interactions. Eur. J. Pharmacol. 121:1986;9-18.
7. Contreras P.C., Ragan D.M., Bremer M.E., Lanthorn T.H., Gray N.M., Iyengar S., Jacobson A.E., Rice K.C., De Costa B.R. Evaluation of U50,488H analogs for neuroprotective activity in the gerbil. Brain Res. 546:1991;79-82.
8. Dalkara S., Calis U., Sunal R. Synthesis and anticonvulsant activity of some new 2(3H)-benzoxazolone derivatives. J. Pharm. Belg. 43:1988;372-378.
9. 3H ] (+)-pentazocine to σ recognition sites in guinea pig brain Eur. J. Pharmacol. 227:1992;371-378.
10. 3H ](+)-pentazocine-defined sigma recognition sites by phenytoin Life Sci. 53:1993;41-48.
11. Deutsch S.I., Weizman A., Goldman M.E., Morihasa J.M. The sigma receptor: A novel site implicated in psychosis and antipsychotic drug efficacy. Clin. Neuropharmacol. 11:1988;105-119.
12. Gillan M.G.C., Kosterlitz H.W., Paterson S.J. Comparison of the binding characteristics of tritiated opiates and opioid peptides. Br. J. Pharmacol. 70:1980;481-490.
13. Gilligan P.J., Kergaye A.A., Lewis B.M., McElroy J.F. Piperidinyltetralin sigma ligands. J. Med. Chem. 37:1994;364-370.
14. Gundlach A.L., Largent B.L., Snyder S.H. Phencyclidine and sigma opiate receptors in brain: Biochemical and autoradiographic differentiation. Eur. J. Pharmacol. 113:1985;465-466.
15. 1-binding site. Proc. Natl. Acad. Sci. U.S.A. 93:1996;8072-8077.
16. Hellewell S.B., Bowen W.D. A sigma-like binding site in rat pheochromocytoma (PC12) cells: Decreased affinity for (+)-benzomorphans and lower molecular weight suggest a different sigma receptor form from that of guinea pig brain. Brain Res. 527:1990;244-253.
17. 1 recognition sites. Eur. J. Pharmacol. 271:1994;235-236.
18. Itzhak Y., Stein I. Regulation of σ receptors and responsiveness to guanine nucleotides following repeated exposure of rats to haloperidol: Further evidence for multiple σ binding sites. Brain Res. 566:1991;166-172.
19. Jerram A.H., Smith P.F., Darlington C.L. The effects of (+)-SKF10047 and ketamine hydrochloride on stereotyped behavior, locomotor activity and ataxia in guinea pig. Eur. J. Pharmacol. 307:1966;269-273.
20. 3H ]-3-PPP label pharmacologically distinct σ binding sites in guinea pig brain membranes Eur. J. Pharmacol. 193:1991;21-27.
21. Krall R.L., Penry J.K., White B.G., Kupferberg H.J., Swinyard E.A. Antiepileptic drug development: II. Anticonvulsant drug screening. Epilepsia. 19:1978;400-428.
22. 3H ]3-3(3-hydroxyphenyl)-N-(1-propyl) piperidine Proc. Natl. Acad. Sci. USA. 81:1984;4983-4987.
23. 2 receptors. Life Sci. 57:1995;PL57-PL62.
24. Marquis K.L., Paquette N.C., Gussio R.P., Moreton J.E. Comparative electroencephalographic and behavioral effects of phencyclidine, (+)-SKF-10,047 and MK-801 in rats. J. Pharmacol. Exp. Ther. 251:1989;1104-1112.
25. Martin W.R., Eades C.E., Thompson J.A., Huppler R.E. The effects of morphine-and nalorphine-like drugs in the nondependent and morphine-dependent chronic spinal dog. J. Pharmacol. Exp. Ther. 197:1976;517-532.
26. Matsumoto R.R., Hemstreet M.K., Lai N., Thurkauf A., De Costa B.R., Rice K.R., Hellewell S.B., Bowen W.D., Walker J.M. Drug specificity of pharmacological dystonia. Pharmacol. Biochem. Behav. 36:1990;151-155.
27. 1 receptor agonist. Eur. J. Pharmacol. 306:1996;271-279.
28. McLean S., Weber E. Autoradiographic visualization of haloperidol sensitive sigma receptors in guinea-pig-brain. Neuroscience. 25:1988;259-269.
29. McPherson G.A. Analysis of radioligand binding experiments. A collection of computer programs for the IBM PC. J. Pharmacol. Methods. 14:1985;213-228.
30. Mendelsohn L.G., Kalra V., Johnson B.G., Kerchner G.A. Sigma opioid receptor: Characterization and co-identity with the phencyclidine receptor. J. Pharmacol. Exp. Ther. 233:1985;597-602.
31. 3 dorsal hippocampus by sigma ligands. J. Pharmacol. Exp. Ther. 261:1992;123-130.
32. Munson P.J., Rodbard D. LIGAND: A versatile computerized approach for characterization of ligand-binding systems. Anal. Biochem. 107:1980;220-239.
33. Porter R.J., Cereghino J.J., Gladding G.D., Hessie B.J., Kupferberg H.J., Scoville B., White B.G. Antiepileptic drug development program. Clevel. Clin. Q. 51:1984;293-305.
34. Quirion R., Bowen W.D., Itzhak Y., Junien J.L., Musacchio J.M., Rothman R.B., Su T.P., Tam S.W., Taylor D.P. A proposal for the classification of sigma binding sites. Trends Pharmacol. Sci. 13:1992;85-86.
35. 3H ]SKF 10,047 binding in rat and mouse brain: Further evidence for phencyclidine/'sigma opiate' receptor commonality J. Pharmacol. Exp. Ther. 237:1986;681-688.
36. Snyder S.H., Largent B.L. Receptor mechanisms in antipsychotic drug action: Focus on sigma receptors. J. Neuropsychiatry. 1:1989;7-15.
37. 3H ]-SKF-10047 to etorphine-inaccessible sites in guinea pig brain J. Pharmacol. Exp. Ther. 223:1982;284-290.
38. Su T.P., London E.D., Jaffe J.H. Steroid binding at σ receptors suggest a link between endocrine, nervous, and immune systems. Science. 240:1988;219-221.
39. Tam S.W. Naloxone-inaccessible sigma receptor in rat central nervous system. Proc. Natl. Acad. Sci USA. 80:1983;6703-6707.
40. 2 receptor antagonist: Receptor binding, electrophysiological and neuropharmacological profiles. J. Pharmacol. Exp. Ther. 263:1992;1167-1174.
41. Tortella F.C., Witkin J.M., Musacchio J.M. Caramiphen: A non-opioid antitussive with potent anticonvulsant properties in rats. Eur. J. Pharmacol. 155:1988;69-75.
42. 3H ]-N-Methylscopolamine binding to muscarinic receptors in the rat central nervous system: Evidence for the existence of three classes of binding sites Mol. Pharmacol. 30:1986;305-314.
43. Walker J.M., Matsumoto R.R., Bowen W.D., Gans D.L., Jones K.D., Walker F.O. Evidence for a role of haloperidol-sensitive sigma opiate receptors in the motor effects of antipsychotic drugs. Neurology. 38:1988;961-965.
44. Walker J.M., Bowen W.D., Walker F.O., Matsumoto R.R., De Costa B., Rice K.C. Sigma receptors: Biology and function. Pharmacol. Rev. 42:1990;355-402.
45. 2 receptors in motor function. Eur. J. Pharmacol. 231:1993;61-68.
46. 1 site. J. Neurosci. 15:1995;731-736.
47. Zukin S.R., Brady K.T., Slifer B.L., Balster R.L. Behavioral and biochemical stereo-selectivity of sigma opiate/PCP receptors. Brain Res. 294:1984;174-177.